Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2025)

Historic Receivables - Net for Nurix Therapeutics (NRIX) over the last 4 years, with Q2 2025 value amounting to $19.0 million.

  • Nurix Therapeutics' Receivables - Net changed N/A to $19.0 million in Q2 2025 from the same period last year, while for May 2025 it was $19.0 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2021, which is N/A changed from last year.
  • Nurix Therapeutics' Receivables - Net amounted to $19.0 million in Q2 2025.
  • In the past 5 years, Nurix Therapeutics' Receivables - Net registered a high of $19.0 million during Q2 2025, and its lowest value of $2.0 million during Q3 2023.
  • Its 4-year average for Receivables - Net is $7.1 million, with a median of $6.0 million in 2021.